Cite
HARVARD Citation
Djebbari, F. et al. (2023). Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients. British journal of haematology. pp. 162-167. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Djebbari, F. et al. (2023). Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients. British journal of haematology. pp. 162-167. [Online].